Ang Lifesciences India Limited (ANG) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE236W01016
Key metrics
- Market Cap
- ₹33 Cr
- P/E Ratio
- —
- EPS
- -8.49
- Book Value
- 40.5
- P/B Ratio
- 0.63
- ROE
- -20.96%
- ROCE
- -4.25%
- Debt / Equity
- 1.5
- Net Margin
- -11.93%
- Revenue Growth
- 0.05%
- Profit Growth
- 10.7%
- Dividend Yield
- —
- 52W High
- ₹49.69
- 52W Low
- ₹17.63
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Ang Lifesciences India Limited
ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. The company offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, and lotions. ANG Lifesciences India Limited was incorporated in 2006 and is based in Amritsar, India.
- Headquarters
- Amritsar, India
- Employees
- 412
- Promoter Holding
- 70.6%
The full Ang Lifesciences India Limited analysis
Create a free account to open the complete ANG deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.